New asthma injection targets lung inflammation
Disease control
Recruiting now
This study is testing a new long-acting injectable medicine called WIN378 for adults with moderate or severe asthma. WIN378 works by blocking a protein (TSLP) that causes lung inflammation. Over 48 weeks, researchers will measure how the body processes the drug, check its safety,…
Phase: PHASE2 • Sponsor: Windward Bio • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC